Related references
Note: Only part of the references are listed.Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy
Lori J. Pierce et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
Tomasz Byrski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Familial Breast Cancer Clinical Response to Induction Chemotherapy or Radiotherapy Related to BRCA1/2 Mutations Status
Alain Fourquet et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2009)
Long-term outcome after neo-adjuvant chemotherapy for breast cancer in BRCA1/2 carriers
Annick Wong Wong Keet et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Monika K. Graeser et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
Timothy R. Rebbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases
C. T. M. Brekelmans et al.
EUROPEAN JOURNAL OF CANCER (2007)
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer
LJ Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Survival and prognostic factors in BRCA1-associated breast cancer
CTM Brekelmans et al.
ANNALS OF ONCOLOGY (2006)
Breast cancer risk following bilateral oophorectorny in BRCA1 and BRCA2 mutation carriers:: An international case-control study
A Eisen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2- A clinic-based series
M Robson et al.
CANCER (2005)
The role of BRCA1 in the cellular response to chemotherapy
RD Kennedy et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
K Metcalfe et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment
ME Robson et al.
BREAST CANCER RESEARCH (2004)
Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy
C Seynaeve et al.
EUROPEAN JOURNAL OF CANCER (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer
PO Chapppuis et al.
JOURNAL OF MEDICAL GENETICS (2002)
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status
BG Haffty et al.
LANCET (2002)
Low expression of bcl-2 in Brca1-associated breast cancers
P Freneaux et al.
BRITISH JOURNAL OF CANCER (2000)
BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines
M Thangaraju et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
A Bhattacharyya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer
LC Verhoog et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
